Korean guidelines for the treatment of panic disorder

被引:1
|
作者
Suh, Ho-Suk [1 ]
Lee, Jae-Hon [2 ]
Gim, Min-Sook [3 ]
Kim, Min-Kyoung [1 ]
机构
[1] CHA Univ, Sch Med, Dept Psychiat, Seoul, South Korea
[2] Korea Univ, Coll Med, Dept Psychiat, Seoul, South Korea
[3] Inje Univ, Coll Med, Dept Psychiat, Seoul, South Korea
来源
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | 2018年 / 61卷 / 08期
关键词
Panic disorder; Guideline; Pharmacotherapy; Cognitive therapy;
D O I
10.5124/jkma.2018.61.8.493
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The Korean Association of Anxiety Disorders developed a Korean guideline for the treatment of panic disorders in 2018 to help clinicians make treatment decisions. This study investigated the consensus about treatment strategies for initial and maintenance treatment, non-responsive cases, comorbid conditions, and psychotherapy in patients with panic disorder. The executive committee developed questionnaires about treatment strategies for patients with panic disorder based on guidelines, algorithms, and clinical trials previously published in foreign countries and Korea. Seventy-two 61% of 112 experts on a committee reviewing panic disorders responded to the questionnaires. We classified the consensus of expert opinions into 3 categories (first-line, second-line, and third-line treatment strategies) and identified the treatment of choice according using the chi-square test and 95% confidence intervals. This study presents useful information about the consensus among Korean experts regarding pharmacotherapy and cognitive behavior therapy for patients with panic disorder.
引用
收藏
页码:493 / 499
页数:7
相关论文
共 50 条
  • [41] BRIEF STRATEGIC THERAPY IN PANIC DISORDER TREATMENT
    Iengo, Andrea
    PSYCHIATRIA DANUBINA, 2020, 32 : 75 - 78
  • [42] Effectiveness: the treatment of panic disorder in the real world
    Furukawa, TA
    CURRENT OPINION IN PSYCHIATRY, 2003, 16 (01) : 45 - 48
  • [43] The role of alprazolam for the treatment of panic disorder in Australia
    Moylan, Steven
    Giorlando, Francesco
    Nordfjaern, Trond
    Berk, Michael
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 (03) : 212 - 224
  • [44] PHARMACOGENETIC TESTING IN TREATMENT-RESISTANT PANIC DISORDER: A PILOT STUDY
    Freire, Rafael
    Fidry, Marcos
    Zugliani, Morena
    Cabo, Mariana
    Faria, Clara
    Nardi, Antonio
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i106 - i107
  • [45] Can psychopharmacological treatment change personality traits in patients with panic disorder?
    Kipper, Leticia
    Wachleski, Claudia
    Salum, Giovanni Abrahao
    Heldt, Elizeth
    Blaya, Carolina
    Manfro, Gisele Gus
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2009, 31 (04) : 307 - 313
  • [46] Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder
    Levitan, Michelle Nigri
    Chagas, Marcos H.
    Linares, Ila M.
    Crippa, Jose A.
    Terra, Mauro B.
    Giglio, Alcir T.
    Cordeiro, Joana L. C.
    Garcia, Giovana J.
    Hasan, Rosa
    Andrada, Nathalia C.
    Nardi, Antonio E.
    REVISTA BRASILEIRA DE PSIQUIATRIA, 2013, 35 (04) : 406 - 415
  • [47] Pathological Worry is Related to Poor Long-Term Pharmacological Treatment Response in Patients With Panic Disorder
    Kim, Hyun-Ju
    Kim, Ji Eun
    Lee, Sang-Hyuk
    PSYCHIATRY INVESTIGATION, 2021, 18 (09) : 904 - 912
  • [48] Mirtazapine versus fluoxetine in the treatment of panic disorder
    Ribeiro, L
    Busnello, JV
    Kauer-Sant'Anna, M
    Madruga, M
    Quevedo, J
    Busnello, EAD
    Kapczinski, F
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2001, 34 (10) : 1303 - 1307
  • [49] Panic disorder: Clinical features and treatment approaches
    Chutko, L. S.
    Surushkina, S. Yu.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (08) : 133 - 137
  • [50] Anxiety sensitivity and treatment outcome in panic disorder
    Hazen, AL
    Walker, JR
    Eldridge, GD
    ANXIETY, 1996, 2 (01): : 34 - 39